Englander Institute for Precision Medicine
EIPM Clinical Director Dr. Cora N. Sternberg

Dear Friends & Members of the Englander Institute,

ImageWe hope you enjoy the new video, "...

News from the EIPM

Many of health care’s toughest challenges—from delayed diagnoses to inefficient clinical workflows—are waiting for creative solutions. At the Cornell Health AI Hackathon, student teams spent an intense weekend racing to build some of them.

More than 100 students...

Dr. Carolina Reduzzi

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. 

The findings highlight the potential importance of these under-studied cells in breast cancer progression.

Circulating tumors cells are breakaway tumor cells that can seed secondary tumors (...